8.- Hepatitis tóxicas y fulminantes.
Vigorous response of cytotoxic T lymphocytes associated with
systemic activation of CD8 T lymphocytes in fulminant hepatitis B. Kondo
Y, Kobayashi K, Asabe S, et al. Liver International 2004;24:561-7.
Importante activación de los linfocitos
CD8 en la hepatitis fulminante por VHB.
Recognition of Nonhepatic Coma in the Setting of Acetaminophen
Overdose. Aftab Ala, Thomas Schiano, Andrew Burroughs, et al. Digestive
Diseases and Science 2004;49: 1977-1980.
Caso clínico.
Subfulminant liver failure associated with quetiapine. El
Hajj I, Sharara AI, Rockey DC. European Journal of Gastroenterology and
Hepatology 2004;16:1415-8.
Caso clínico.
Bioartificial liver in acute liver failure: Impostor or simply
misunderstood? O'grady J. Hepatology 2004;41:
Editorial.
Strategies for liver support: from stem cells to xenotransplantation.
Burra P, Samuel D, Wendon J, Pietrangelo A, Gupta S. Journal of Hepatology
2004;41:1050-9.
Revisión.
Acute hepatitis of cholestatic type possibly associated with
the use of glucomannan (amorphophalus konjac). Fernández-Villaverde
A, Benlloch S, Berenguer M, Rayón JM, Pina R, Berenguer J. Journal
of Hepatology 2004:41:1061-2.
Carta.
Severe hepatotoxicity associated with the use of weight loss
diet supplements containing ma huang or usnic acid. Neff GW, Reddy KR, Durazzo
FA, Meyer D, Marrero R, Kaplowitz N. Journal of Hepatology 2004;41:1062-4.
Carta.
